echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > HSD3B1 gene studies have shown that genotype is associated with endometrial cancer

    HSD3B1 gene studies have shown that genotype is associated with endometrial cancer

    • Last Update: 2022-09-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    CLEVELAND – According to a new finding from the Cleveland Clinic's Lerner Institute, the HSD3B1 gene may provide clues


    Based on the findings published in the JNCI Cancer Spectrum, the researchers found that a certain HSD3B1 genotype is more common


    The result is the latest step in unlocking the role that HSD3B1 genotype plays in hormone-driven cancer, after previous studies have revealed its association


    Nima Sharifi, MD, senior author of the paper and director of the Research Center for Genitourinary Malignancies at the Lerner Institute, said HSD3B1 researchers are laying the groundwork for future treatment and prevention of cancer subtypes with lower survival rates


    Although endometrial cancer is one of the most common cancers in women, there are currently no tests or tests to screen for endometrial cancer


    "We haven't changed the criteria for results over the last 30 years," Dr.


    HSD3B1 is a gene


    Dr.


    Previous studies have determined how the HSD3B1 gene works, and how it relates to hormone-associated cancers, starting


    Dr.


    The purpose of castration is to stop the production


    Dr.


    Recent studies have investigated a potential link between the genotype of HSD3B1 and subtypes of postmenopausal breast and endometrial cancer in which cancer grows


    Previous studies have linked


    In endometrial cancer, the serous subtype ER is less expressed and the prognosis is poor


    Lead author Dr.


    Ongoing HSD3B1 collaborations include further research into the relationship of HSD3B1 to breast and endometrial cancers, as well as studies of how HSD3B1 is associated
    with radiotherapy responses.
    A clinical trial of prostate cancer at the Cleveland Clinic will test how people with a specific HSD3B1 genotype respond
    to treatment.

    The authors note that black women are more likely to inherit the HSD3B1 gene that restricts adrenal secretion, and that certain breast and endometrial cancer subtypes have worse outcomes, both of which are more common
    in black women.
    A study released in May by the National Cancer Institute showed that black women were twice as likely to die from uterine cancer as
    other ethnic groups.

    "Eliminating this difference in outcomes and trying to understand the genetic basis will be critical
    to reducing (or eliminating) existing differences," Vargas said.

    essay

    Association between adrenal-restrictive HSD3B1 inheritance and hormone independent subtypes of endometrial and breast cancer


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.